Animal fetuses and embryos may have applications in the generation of human organs. Progenitor cells may be an appropriate cell source for regenerative organs because of their safety and availability. However, regenerative organs derived from exogenous lineage progenitors in developing animal fetuses have not yet been obtained. Here, we established a combination system through which donor cells could be precisely injected into the nephrogenic zone and native nephron progenitor cells (NPCs) could be eliminated in a time- and tissue-specific manner. We successfully achieved removal of Six2+ NPCs within the nephrogenic niche and complete replacement of transplanted NPCs with donor cells. These NPCs developed into mature glomeruli and renal tubules, and blood flow was observed following transplantation in vivo. Furthermore, this artificial nephron could be obtained using NPCs from different species. Thus, this technique enables in vivo differentiation from progenitor cells into nephrons, providing insights into nephrogenesis and organ regeneration.
Fetuses complete the complex process of nephrogenesis (kidney development) within a set time while still inside the mother’s uterus1. Thus, renal regeneration may become feasible if the developmental program could be completely recapitulated2. However, the development of organs during the fetal period is subject to complex spatiotemporal regulation, making regeneration of the kidney in a dish exceedingly difficult. For this reason, we have developed a strategy for applying multipotent stem cells at the niche of organogenesis2,3,4,5,6,7,8. This strategy involves transplantation of human cells into the area of nephrogenesis in a fetus of a different animal species, thereby generating human cell-derived kidneys2.
Gardner and Jhonson reported the generation of a rat-mouse chimera by injection of inner cell mass into blastocysts9, demonstrating that certain differentiation signals could be shared between species. Many researchers have attempted to explore interspecies chimeras or chimeric organs using embryos and fetuses of different animals10. Using such technology, attempts to regenerate solid organs, such as pancreases and kidneys, in xeno-animals have recently been made using blastocyst complementation, in which embryonic stem (ES) cells or induced pluripotent (iPS) cells are injected into blastocysts lacking key molecules to generate the organ of interest11, 12. However, due to the pluripotency of the injected cells, their progeny may be disseminated throughout the chimera, resulting in serious ethical concerns with regard to contribution to host gametes or neural tissues. To overcome these problems, researchers have attempted to control chimerism using the Mixl1 gene to regulate the endodermal lineage or Sox17+ endoderm progenitors injected into blastocysts expressing the anti-apoptotic gene BCL2 13, 14.
Additionally, injection of lineage progenitors into early-stage embryos is not sufficient for organ regeneration after implantation10, 14, 15. Instead, transplantation of donor cells into developmental stage-matched host embryos may be critical for the efficient engraftment of cells in generating chimeras15. Moreover, whole organ regeneration has not yet been performed with injection or transplantation of lineage progenitors as donor cells into the later stage fetus (postimplantation) or lineage niche10, 15. In this context, it is necessary to develop a system in which the organ of interest is exclusively rebuilt in the chimera using organ-specific progenitor cells.
Since the differentiation potency of progenitor cells is limited by certain lineages, they are extremely unlikely to affect the central nervous system or reproductive system across germ layers. Additionally, renal progenitor cells have recently been induced from iPS/ES cells16,17,18,19, and advancements in technology have made large-scale culture of these cells a possibility20, 21. Therefore, progenitor cells may be able to serve as a promising source of regenerative organs in the future. When progenitor cells are used as donor cells, the host fetus should be in the later stages of development for stage-matching10. For example, nephron progenitor cells (NPCs) exist from embryonic day 10.5 (E10.5) to the early neonatal stage in mice1, 22. Therefore, we hypothesized that it would be optimal to transplant progenitor cells into a fetus during this specific period and assumed that this method of exploiting limited chimeras may prove useful for organ regeneration.
We previously reported that injection of human mesenchymal stem cells expressing glial-derived neurotrophic factor into the nephrogenic niche of the developing fetus may result in the formation of chimeric kidneys in the host compartment2, 3. However, injection of cells into the nephrogenic niche at the initial budding from the Wolffian duct before nephrogenesis is technically difficult and cannot be applied for larger animals. Therefore, it is necessary to establish a system that is technically sound and can be applied for larger animals to efficiently inject donor cells into the nephrogenic niche.
Accordingly, in the present study, we established a technical method through which donor cells could be precisely injected at the nephrogenic zone of the mouse metanephros (MN), where injected cells are continuously developed at later stages of kidney development. The nephrogenic zone was defined as the layer under renal capsule in which there was a plural number of nephrogenic niches23, 24. Thus, we attempted to transplant cells NPCs, which were from developmental stage-matched host embryos, into the nephrogenic zone to form whole nephrons. Although several reports have described sporadically attempts to transplant cells into the MN25, 26, these attempts have not been sufficiently successful, and even when nephrons have been regenerated, they have been reported to contain a mixture of host and donor cells, the latter of which should be fully replaced by native host progenitor cells to generate whole kidneys. We further established a system in which native NPCs were eliminated in both a time- and tissue-specific manner to allow external NPCs to develop to form whole nephrons and evaluated the ability of these nephrons to develop into mature glomeruli and renal tubules by integrating with the vasculature of the host animal following transplantation in vivo. We also injected rat NPCs into mouse MNs in the elimination model, generating chimeric nephrons. These results provided insights into donor NPC-derived kidney regeneration in the organ niche of another species.
Transplantation of NPCs under the renal capsule of the MN
To evaluate whether isolated NPCs could be integrated into the CM region, which is the origin of nephron development, we attempted transplantation into the nephrogenic zone of the MN at the same embryonic stage. First, we isolated NPCs from E13.5 embryos of mice expressing green fluorescent protein (GFP) under the control of the ubiquitously expressed CMV-β-actin promoter (CAG-GFP mice). These GFP-expressing NPCs (GFP-NPCs) were then transplanted into the E13.5 MN of B6 mice. After 5–7 days of organ culture, the samples were subjected to histological analysis via immunostaining. We transplanted the NPCs by simply applying them around the MN (outside MN group; Fig. 1a, left column). However, NPCs did not integrate into the nephrogenic zone and CM (Fig. 1b, upper and 1c, left).
The renal capsule contains a cell layer of tight junctions27. Therefore, we assumed that the capsule layer may prevent integration of NPCs into the CM. We attempted to transplant NPCs directly into the nephrogenic zone by inserting them under the renal capsule of the MN (Fig. 1a, right and 1b, lower). Notably, GFP-NPCs inserted into the nephrogenic zone in this group integrated into the CM region around the ureteric tips (Fig. 1c, right and 1d, right). In contrast, the outside group exhibited no GFP-positive cells in the proximity of the ureteric tips (Fig. 1c, left and 1d, left). These integrated GFP-positive cells expressed Six2 and thus were thought to constitute Six2-positive NPCs (Six2+NPCs; Fig. 1d, right and 1e). Furthermore, transplanted and integrated GFP-expressing cells were also observed on some C-shaped nephrons in the inside MN group (Fig. 1e). These cells were shown to possess the potency to differentiate into nephrons by receiving subepithelial signals (Fig. 1e). However, these early renal vesicles had a mosaic structure (Fig. 1e, yellow arrowhead and Supplementary Movie 1). Although a previous study demonstrated that NPCs transplanted into the MN can differentiate into mosaic nephrons25, no attempts were made to transplant cells under the renal capsule. The original method facilitated the transplantation of a larger number of cells into the nephrogenic zone (Fig. 1f, right schematic and Supplementary Movie 2). In the inside wild-type MN group, the integration rate of cells was about 30% for each ureteric tip in the CM region (Fig. 2a, Table 1). Importantly, although the integration of NPCs into the CM was good, this method did not achieve complete replacement of NPCs or regeneration of pure nephrons. Instead, this method yielded a cell composition that was a mixture of both transplanted and host-derived cells in the CM region, with the differentiated nephrons forming mosaics.
Evaluation of the cell elimination system
The wild-type MN occupied the CM area through host NPCs; therefore, complete replacement of CM cells by donor cells was limited in the wild-type MN. Accordingly, we attempted to eliminate host NPCs in the CM. To design a system that could specifically eliminate all NPCs present in the CM, we hybridized Six2-GFPCre mice22 with Cre-inducible diphtheria toxin (DT) receptor (iDTR) transgenic mice28. The resulting mice (Six2-GFPCre+; iDTR+ mice) are referred to as Six2-iDTR mice (Fig. 3a). Six2-GFPCre mice were heterozygotes, and iDTR+ mice were homozygotes. The Six2-iDTR embryos were obtained at expected Mendelian ratios (half ratios).
The MN isolated from each Six2-iDTR mouse was subjected to organ culture (Transwell). DT was dispensed into organ culture chambers at varying concentrations from 0.001 to 0.1 ng/µL and was administered for 5 days after the medium was replaced (Fig. 4). As a result, GFP expression was absent by day 3 at all concentrations (Fig. 4), and higher DT concentrations resulted in earlier elimination of GFP expression. When DT was administered 100 µL at 0.1 ng/µL (10 ng/well), GFP expression was eliminated by 36 h after administration (Fig. 3b). After Six2-DTR MNs were cultured from day 0 (first day of culture) to day 5 in the presence of 0.1 ng/µL DT, the CM exhibited almost no signs of Six2- or GFP-expressing cells on day 5 (Fig. 3c, lower). Compared with that in the untreated control group, the DT-treated group displayed poor branching of the ureteric bud29, which did elongate but had an extremely deformed shape with many distortions (Fig. 3c, lower right). Continuous DT administration to the Six2-iDTR MN resulted in almost complete elimination of Six2-positive NPCs by day 5, and the expression of Six2 was abolished as early as approximately 36–48 h after DT administration (Fig. 3a, low and Fig. 4).
Renal regeneration by the cell elimination system
We hypothesized that we may be able to regenerate kidneys by transplanting new DT-uneffective NPCs into the nephrogenic zone simultaneously with DT-mediated elimination of host Six2-NPCs. Accordingly, we first isolated the MN from E13.5 Six2-iDTR mice and then transplanted GFP-NPCs or DsRed-NPCs collected from E13.5 CAG-GFP mice or mice expressing DsRed under the same promoter (CAG-DsRed mice) without DT receptor (DTR) expression into the nephrogenic zone under the renal capsule (Fig. 5a, top and 5d, top). Each MN was subjected to organ culture and was administered DT at 0.1 ng/µL starting from day 0. Analysis performed on days 5–7 revealed that despite continuous administration of DT, GFP-positive or DsRed-positive transplanted cells expressing Six2 existed on the CM (Fig. 2b, Fig. 5a, top and right column and 5b and 5d, top). Post-transplanted NPCs were fully replaced in the CM of the elimination model (Figs. 2 b and 5d, top right column). Sufficient replacement required elimination of host NPCs. Daily DT administration caused almost complete elimination of Six2-positive cells (Fig. 5a, second from bottom and 5d, second from top). When no DT was administered, only the Six2-positive cells in the Six2-iDTR MN expressed GFP, whereas epithelialized nephrons including glomeruli and renal tubules did not (Fig. 5a, bottom and 5d, bottom). However, when GFP-NPCs or DsRed-NPCs were transplanted into the Six2-iDTR MN along with DT administration, we observed GFP- or DsRed-expressing Wilms tumor 1 (WT1)-positive glomeruli (Fig. 5c, right, Fig. 5e, and Supplementary Movies 3–5), E-cadherin-positive distal convoluted tubules (Fig. 5e, bottom column), and Lotus tetragonolobus lectin (LTL)-positive proximal convoluted tubules (Fig. 5c, left). These regenerative nephron structures were shown to be connected to the collecting duct derived from the host ureteric bud (Fig. 5c, yellow arrowhead and line, Fig. 5e second from bottom, bottom column, and Supplementary Movies 5 and 6). To determine whether cell transplantation inhibited the activity of DT and impeded cell elimination from the CM, we transplanted fibroblasts extracted from DsRed mice into the Six2-iDTR MN. In this case, no Six2-positive cells occurred in the CM of the host (Fig. 6).
By eliminating existing NPCs simultaneously with cell transplantation into nephrogenic zone and replacing them with transplanted cells, we succeeded in regenerating nephrons that were completely derived from transplanted NPCs. This method was very simple and exhibited a high success rate. However, the collecting duct and ureter were not differentiated by the transplanted cells. NPCs from the metanephric mesenchyme lineage differentiate into nephrons; however, the collecting duct and ureter are derived from the ureteric epithelium lineage18. This is the first report of renal regeneration focusing on Six2-positive NPCs in which donor NPCs were replaced.
In vivo renal regeneration by the cell elimination system
For examination of integration and connection of the vasculature in the neonephron and examination of the further development of the neonephron, we evaluated a system in which renal regeneration was mediated by the replacement of NPCs in vivo.
First, we injected GFP- or DsRed-NPCs plus DT below the renal capsule of an isolated Six2-iDTR MN (Fig. 7a, b and Supplementary Movie 2) and then transplanted the Six2-iDTR MN containing DT-uneffective exogenous NPCs into the proximity of the aorta of B6 mice (Fig. 7c, left and 7f, schematic). The transplanted MN was not separated from the ureter and bladder, but was instead isolated as a whole with these components connected and subsequently transplanted as an MNB (Fig. 7a, right and 7b, right).
On day 14, the MNB was recovered and prepared as frozen sections (Fig. 7c, right and second from right), which were then subjected to immunostaining (Fig. 7d, left). As a result, GFP-NPCs-derived glomeruli were found to have formed within the transplanted Six2-iDTR MN. The glomeruli expressed GFP and had a podocin-positive loop wall (Fig. 7d, second from left, Supplementary Movie 7). CD31-positive vascular endothelial cells were found within these regenerated glomeruli (Fig. 7d, left, second from right). Furthermore, hematoxylin−eosin staining revealed the presence of erythrocytes within the glomeruli, implying their connection to host blood vessels and inflow of blood (Fig. 7, right). Electron microscopic observation of these glomeruli detected glomerular tuft structures and brush borders of renal tubules (Fig. 7e). As above, we were able to reproduce in vivo renal regeneration mediated by the replacement of NPCs, and the neoglomerulus acquired a vascular system by becoming integrated into host blood vessels.
Generation of interspecies chimeric whole nephrons
By transplanting rat GFP-NPCs into the Six2-iDTR MN of mice, we examined interspecific renal regeneration (Fig. 8f, schematic). The transplanted rat NPCs were subjected to immunostaining 5–7 days after transplantation. As a result, Six2-positive cells of rats were observed in the CM of mice. In these Six2-positive cells, mouse-derived NPCs had been eliminated with DT, thus providing support for the integration of rat-derived NPCs into the mouse-derived CM and ureteric tip (Fig. 8a, left, 8b, and 8c). Pax8 is a transcriptional factor which marked fusion of the renal vesicle with the ureteric tip at the late renal vesicle stage30. Further, E-cadherin is expressed in the distal renal epithelium of the fused nephron with late stage nephron30 (Fig. 8d). Transplanted rat GFP-NPCs were connected to the mouse ureteric bud (Fig. 8c, d). The anti-vimentin monoclonal antibody V9 was used for species-specific detection in rats but not mice31. Immunofluorescence microscopy showed that the transplanted rat GFP-NPCs were stained by rat-specific anti-vimentin antibodies, whereas the mouse ureteric bud was not stained with anti-vimentin antibodies (Fig. 8e). Rat NPCs were replaced by mouse NPCs (Fig. 8b, Supplementary Movie 8). Furthermore, following differentiation into glomeruli and renal tubules, the cells also showed positive staining for WT1 and E-cadherin (Fig. 8c and d). These results demonstrated that renal regeneration mediated by the replacement of NPCs was also possible between different species.
In this study, we used a combination of a specified cell injection method and a drug-induced cell elimination system to exchange native NPCs with exogenous NPCs and generate regenerative nephrons from transplanted NPCs (Fig. 5e and Supplementary Movies 3–6). Most importantly, we succeeded in generating interspecies nephrons in Six2-iDTR mice via replacement of different species of rat NPCs using a drug-induced cell elimination system (Fig. 8). In brief, the present study yielded the following three major findings: (1) nephrons could be generated by transplanting NPCs in the nephrogenic niche of a fetus; (2) elimination of host NPCs in the nephrogenic zone could be achieved by injection with external NPCs, allowing them to develop further to nephrogenesis; and (3) such a system could be applied for generating interspecies nephrons.
We believe that tissue-specific progenitor cells are superior to pluripotent stem cells (PSCs) because, due to their limited differentiation capacity9, organ regeneration may be restricted, and other organs may not be affected in the chimeras, thereby avoiding ethical concerns. Additionally, several recent protocols have been developed to establish organ-specific progenitor cells from PSCs, such as ES cells and iPS cells, making this system feasible for drug screening and in vivo evaluation in disease models by establishing patient-derived nephrons15,16,17,18,19.
The advantage of using an elimination system is that donor NPCs can exclusively exploit the developmental program of the developing host embryo, thus making it possible to obtain nephrons consisting purely of the donor cells (Fig. 2b, Fig. 5d, top, Fig. 8a–d, Supplementary Movie 8). Since the drug-induced system can specify the period and parts of elimination, other developmental environments will not be disturbed. In particular, the iDTR model, which represents a DT-mediated cell elimination system, proved suitable for cell replacement because it was very expeditious and efficient in elimination cells28, 32, 33. The pancreas, liver, and heart have been reported to be compatible with iDTR-mediated regeneration34,35,35-36. However, application to renal regeneration has not been reported until the present study, in which we attempted to replace progenitor cells as donor cells for the first time. This system takes advantage of the iDTR system to make DT act at specific timing on the target tissue, thereby inducing apoptosis of the target cells in both a time- and tissue-specific manner. We assumed that in order to obtain the normal native organogenesis niche as a biological scaffold, the environment of the niche had to be maintained until just before cell injection. In the present study, we targeted Six2+ NPCs as the cells to be eliminated. In a previous report, adult individuals of the Six2-iDTR strain were used as a pathologic model for chronic kidney disease following acute kidney injury32; however, no studies have been performed to analyze the MN during the embryonic stage. Therefore, it is unclear whether Six2-positive (Six2-expressing) cells can be specifically and completely eliminated by the DT-mediated and cell-specific apoptosis induction system. Six2 is a transcription factor expressed within cells present in the CM during nephrogenesis, and Six2-expressing cells are NPCs capable of differentiating into all nephron components, including podocytes, proximal tubules, the loop of Henle, and distal tubules22. In contrast, the collecting duct system is derived from a different origin, occurring from the ureteric bud. Six2+ NPCs are multipotent progenitor cells that can differentiate into the nephron unit from the glomerulus to the distal tubules and possess vigorous self-renewing ability22. A previous report showed that the Six2-null MN lacked ureteric bud branching and exhibited destruction of the nephrogenic niche37. The MN forms through reciprocal interactions between metanephric mesenchyme in the nephrogenic zone and ureteric bud epithelium38. Therefore, similar to the Six2-knockout model, elimination of the CM cells at the very beginning was predicted to empty the niche37.
In Six2-iDTR mice, Six2+ NPCs started disappearing by approximately 36–48 h after DT administration and were eliminated after consecutive DT administration. Intriguingly, even when NPCs present in the CM were eliminated, the ureteric bud elongated to a certain extent, albeit with poor branching and noticeable distortions that would not be seen in normally branching ureteric buds. This may have been attributable to the elimination of the Six2+ NPCs because the branching process is based on the interaction with NPCs39,40,40-41. However, this conditional elimination system did not induce apoptosis of the ureteric bud cells and not disrupt the ureteric tip, which contained the nephrogenesis area. Thus, we believe that the conditional progenitor cell elimination system, which could be switched according to the specific region and timing, played a key role, supporting the importance of replacing cells simultaneously with or immediately after transplantation.
We aimed to confirm whether the NPC eliminating system could be applied to different species to generate human kidneys, in order to overcome the problems with shortage of organs and to establish a noninvasive system for human drug screening and toxicity analysis of human nephrons in nonhuman animals in vivo. Furthermore, this concept will be useful for improving our understanding of human kidney development and disease mechanisms. Thus, we attempted to transplant rat NPCs into the Six2-iDTR MN of mice. Rat NPCs differentiated into nephrons and connected to the mouse ureteric bud and collecting duct (Fig. 8b, d). We succeeded in generating nephrons via an interspecies. These results suggested that this system was an efficiency method to generate chimeras in more disparate species. Hence, this system is expected to be applicable in pigs, whose organ sizes are similar to those of humans42. Recently, another team reported that human PSCs injected into pig blastocysts may constitute a first step towards realizing the potential of interspecies regeneration in pigs43. Similarly, our strategy using limited chimeras, which targeted the organ niche and lineage progenitors, also suggested the possibility of generating xeno-kidneys in pigs.
For example, NPCs derived from human iPS cells may be transplanted into the nephrogenic zone of the porcine MN, genetically modified to possess a progenitor cell elimination system. Then, modified pig kidneys may function as bioreactors for generation of human nephrons, thus contributing to the creation of chimeric human/pig nephrons. In this study, the function of producing urine was not validated in our rodent system owing to the very small samples. If the system was developed in larger pig fetus kidneys, MNs extracted from the kidney region could be transplanted into adult animals, and the production of urine could be analyzed; such a system may result in improved patient prognosis7. However, the iDTR system cannot be directly applied to human cells because human cells generally express DTR (human heparin-binding epidermal growth) factor-like growth factor. Therefore, we have begun to establish other elimination systems using the CreERT2 system, which is a target of Six2+ NPCs39. This system uses tamoxifen as an elimination switch and is expected to generally have no effect on human cells.
Subsequently, it will be necessary to determine whether NPCs derived from PSCs arise to differentiate into nephrons in this system. Takasato et al. previously reported that the nephron progenitors derived from human ES cells into re-aggregates of mouse kidney cells were differentiated into nephron and expressed developed kidney markers in vitro44. These findings suggested that NPCs derived from human PSCs could be induced by developmental signals in the kidneys of other animals. Another group reported the transplantation of human NPCs derived from iPS cells beneath the kidney capsule of immunodeficient adult mice45. As a result, transplanted human NPCs exhibited immature glomerular formation. Thus, if exogenous NPCs are exposed to an appropriate environment (nephrogenesis niche), glomeruli and tubules can self-organize structures derived from NPCs46. However, it is still necessary to confirm that neo-nephrons derived from human NPCs can connect to nonhuman ureteric buds and collecting ducts. In our proof-of-concept study, we found that exogenous NPCs connected with host ureteric buds in conspecies and interspecies analyses; these are basic findings that provide a positive control for evaluating the differentiation of induced NPCs derived from PSCs.
Recently, Yamaguchi et al. reported that mouse pancreata generated in a xenogeneic (rat) environment by interspecies blastocyst complementation resulted in mouse islets cell-engrafted diabetic mice and normalized blood glucose levels47. Thus, we will plan to apply this approach to our system. Namely, human kidneys will be generated in a xenogenic (pig) environment by elimination of target cells and replacement of exogenous lineage progenitor cells derived from PSCs; the generated human kidneys will be transplanted into patients with end-stage kidney disease. Furthermore, if NPCs derived from PSCs can differentiate into neo-nephrons, this system has the potential for application in drug screening and disease modeling, providing insights into disease mechanisms, drug efficacy, and toxicity in vivo.
In summary, we aimed to utilize the organ niche in fetuses of different species as a platform for organ regeneration; we demonstrated regeneration by transplanting progenitor cells into the organ niche of later stage fetuses. In particular, by conditional elimination of the host progenitor cells in a time- and tissue-specific manner in the nephrogenic niche by the drug-induced cell elimination system in a spatiotemporal manner (summarized in Fig. 8g and Supplementary Movie 9), we successfully replaced the host cells with transplanted cells, thereby regenerating nephrons consisting of donor cells. However, the regenerative kidney remained host tissue, i.e., the ureteric bud lineage and interstitial lineage, and we were unable to replace all kidney structures. The technique developed in the present study may bridge the gap between the goal to regenerate functional organs in vivo and iPS/ES cell technology in a dish, further improving our understanding of kidney development, disease modeling, and drug screening.
Mouse and rat maintenance and experiments
Animal experiments followed the Guidelines for the Proper Conduct of Animal Experiments of the Science Council of Japan (2006) and were approved by the Institutional Animal Care and Use Committee of the Jikei University School of Medicine (protocol number: 2016-027, 2016-089, 25-042C4, 27-14, 28-29, II-28-8). All efforts were made to minimize animal suffering. C57BL6/NCrSlc, C57BL/6-Tg(CAG-EGFP) mice (GFP-mice), and Sprague−Dawley-Tg(CAG-EGFP) rats were purchased from SLC Japan (Shizuoka, Japan). C57BL/6-Gt(ROSA)26Sor[tm1(HBEGF)Awai]/J mice (iDTR-mice)28 and B6.Cg-Tg(CAG-DsRed*MST)1Nagy/J (DsRed-mice) were purchased from Jackson Laboratory (Bar Harbor, ME). Six2-GFP-Cre transgenic mice (Six2-mice) were a gift from McMahon21. Six2-mice were crossed with iDTR-mice to obtain bigenic offspring (Six2/DTR-mice). For renal progenitor cell ablation, Six2-DTR mice were subjected to MN isolation, and MNs were administered with variable doses of diphtheria toxin in organ culture. Mice were bred using timed matings; 12 PM on the day of vaginal plug detection was considered 0.5 days postcoitum (dpc). Both male and female mice were used at 10–25 weeks of age.
Organ culture of isolated MNs
MNs of mouse embryos from B6 mice or Six2/iDTR mice were used. Isolation of MNs from organ cultures was performed as described by Davies48. Briefly, mice were killed by decapitation on E13.5, and MNs were dissected from embryos in Hanks balanced salt solution (Gibco Life Technologies, Grand Island, NY, USA). For in vitro transfilter experiments, isolated MNs of E13.5 embryos were placed at the air−fluid interface on a polycarbonate filter with an average pore size of 0.4 µm (12-mm Transwell; Corning, NY, USA). The medium was α-minimum essential medium (α-MEM; Gibco Life Technologies) supplemented with 20% fetal bovine serum (FBS; Invitrogen) and 1% antibiotic-antimycotic (Gibco Life Technologies). Organs were cultured for 1–7 days at 37 °C with 5% CO2.
NPCs derived from enzymatic dissociation of MNs
MNs (E13.5) were prepared from GFP-mice or DsRed-mice. Dissociation of MNs was performed as described by Davies et al.49. Briefly, E13.5 mouse MNs were dissected in α-MEM. MNs were then collected into 1 mL prewarmed (37 °C) Accutase (Innovative Cell Technologies) and incubated at 37 °C for 15 min, with manual pipetting every 5 min to aid digestion. MNs were then centrifuged at 300×g for 5 min. Pellets were resuspended in 1 mL phosphate-buffered saline (PBS; Gibco Life Technologies) and manually dissociated to single-cell suspensions. Cells were then passed through a 40-μm cell strainer (BD Falcon) to remove any remaining clumps and centrifuged at 700×g for 3 min. The supernatant was removed completely. Tubes were tapped to mix the pellets and incubated on ice until use.
To eliminate Six2-positive NPCs in the present study, we used transgenic mice in which cell death may be induced in a temporally and spatially restricted manner. Apoptosis is induced after DT binds to the DTR28. Because wild-type mice do not express functional DTRs, we used transgenic mice expressing simian DTR in a Cre-recombinase-inducible manner (iDTR mice)28. Six2-Cre mice and iDTR mice were crossbred to generate embryos from which Six2-positive NPCs were eliminated by injection of DT (Wako). DT was dissolved in PBS at 0.1 ng/µL. One hundred microliters of DT (10 ng/well) or vehicle (PBS) was then added to MN culture medium daily for 5–7 days after changing the medium.
Isolation and engrafting of MNs with bladders (MNBs)
Pregnant mice (body weight, 20 g) were anesthetized by 1.5% isoflurane (Pfizer) inhalation. Embryos (E13.5) were harvested, and the pregnant mice were then killed immediately by an infusion of pentobarbital (Schering-Plough; 120 mg/kg). All the embryos were killed by decapitation. MNs or MNBs were dissected under a surgical microscope (Leica MZ16FA), as described previously7. Isolated MNBs (E13.5) from NPCs injected with DT under renal capsule were transplanted under the retroperitoneal vicinity of the descending aorta by microspatula in anesthetized B6 mice.
Injection of NPCs into the nephrogenic zone
B6 (C57BL/6) mice or iDTR mice that were 13.5 days pregnant were killed by dislocation of the cervical vertebrae (Supplemental Movie 2). The fetuses were removed from each specimen through a median incision, along with the uterus, and were then placed in 10-cm dishes containing Ca2+- and Mg2+-free HBSS (Gibco, Invitrogen; Supplementary Movie 2). The fetuses were then extracted from the isolated uterus and killed by decapitation. The joint parts of the hind legs were slit from the caudal side along the spinal cord. Similarly, the other sides were also slit up to remove the vertebral column from the body. After the pair of MNs became visible in the body, the fetus was fixed with microtweezers. Subsequently, a glass needle filled with cells was inserted into the renal membrane from the renal hilus, and the cells were injected with an injector (SBP-100G-LL; TAKASAGO ELECTRIC, Aichi) or by mouth pipetting (Drummond Scientific Company) under a stereoscopic microscope (Leica MZ16FA). The quantity of one injection was approximately 0.1 μL (2×104 cells). After the cells were injected carefully to avoid rupturing the renal capsule, the needle was removed when the nephrogenic zone under the renal capsule was filled with a certain number of cells (0.1–0.4 µL, 2–8×104 cells) (Supplemental Movie 2). The transplanted MNs were detached from the fetuses with the ureter and bladder still connected using microtweezers. The MNs were then subjected to organ culture or were transplanted into adult mice. The extracted specimens (MNBs) were in dishes filled with HBSS until use on ice.
Immunohistological staining of kidney sections and whole specimens was performed as previously described48, 49. Briefly, cryopreserved (7 µm) sections or whole specimens were labeled with primary antibodies, including goat anti-Six2 (Proteintech #11562-1-AP; 1:100 dilution), rabbit anti-WT1 (Santa Cruz Biotechnology #sc-68880; 1:100 dilution), rabbit anti-Podocin (Abcam #ab50339; 1:100 dilution), rat anti-cytokeratin-8 (DSHB #TROMA-1; 1:100 dilution), goat anti-GATA3 (R&D #AF2605; 1:100 dilution), mouse anti-E-cadherin (BD Biosciences #610181; 1:100 dilution), rabbit anti-CD31 (Abcam #ab28364; 1:100 dilution), rabbit anti-Pax8 (Abcam #ab189249; 1:100 dilution), mouse anti-vimentin V9 (Abcam #ab8069; 1:100 dilution), mouse anti-GFP (MBL #M048-3; 1:100 dilution), chicken anti-GFP (Abcam #ab13970; 1:100 dilution), mouse anti-DsRed (Clontech #632393; 1:100 dilution), goat anti-megalin (Santa Cruz Biotechnology #sc-16478; 1:100 dilution), and FITC-conjugated LTL (Vector Laboratories #FL-1321, 1:200 dilution). Slides and whole specimens were subsequently exposed to corresponding secondary antibodies (Thermo Fisher Scientific; 1:100–200 dilution) and mounted with DAPI- containing Prolong-Gold mounting medium (Thermo Fisher Scientific). Staining was examined by fluorescence microscopy (LSM880 confocal, Zeiss and IX-77, Olympus), and semi-automated quantification and 3D construction were performed using IMARIS software (8 series; Bitplane)23.
Measurement of the replacement rate in the cap mesenchyme
Whole immunostained metanephros were imaged using the Zeiss LSM880 confocal microscope (Zeiss). Confocal immunofluorescence images of GFP (green), Six2 (red), and cytokeratin 8 (white) were analyzed. The images were visualized with Imaris (version 8, Bitplane). The ureteric bud tip was manually captured in the software. The numbers of Six2- and GFP-positive cells were determined by the IMARIS spots function algorithm with the following parameters: XY diameter, 6 µm; background subtraction with automatic threshold applied. Red spots are Six2-positive cells. Yellow spots are double positive cells both Six2 and GFP. The fraction of yellow spots in the CM of the total spots is presented as a percentage.
For electron microscopic observation, the specimens were fixed with 2.5% glutaraldehyde and 2% paraformaldehyde mixture in 0.1 m phosphate buffer overnight at 4 °C and then postfixed with 1% osmium tetroxide in the same buffer at 4 °C for 2 h. Dehydration was carried out using a graded ethanol series, and the specimens were then placed in propylene oxide and subsequently embedded in Epok 812 (Oken). Ultrathin sections were prepared with a diamond knife, then stained with uranium acetate and lead citrate solution, and observed using an H-7500 electron microscope (Hitachi) at an accelerating voltage of 80 kV.
Results are expressed as means±standard errors of the means. All assays were repeatable in independent experiments, and the displayed figures are representative of multiple experiments.
All relevant data are available from the authors on request.
Little, M. H. Improving our resolution of kidney morphogenesis across time and space. Curr. Opin. Genet. Dev. 32, 135–143 (2015).
Yokoo, T. et al. Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues. Proc. Natl. Acad. Sci. USA 102, 3296–3300 (2005).
Yokoo, T. et al. Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J. Am. Soc. Nephrol. 17, 1026–1034 (2006).
Fukui, A. et al. Integration of human mesenchymal stem cells into the Wolffian duct in chicken embryos. Biochem. Biophys. Res. Commun. 385, 330–335 (2009).
Gheisari, Y. et al. A thermoreversible polymer mediates controlled release of glial cell line-derived neurotrophic factor to enhance kidney regeneration. Artif. Organs 34, 642–647 (2010).
Matsumoto, K. et al. Xenotransplanted embryonic kidney provides a niche for endogenous mesenchymal stem cell differentiation into erythropoietin-producing tissue. Stem Cells 30, 1228–1235 (2012).
Yokote, S. et al. Urine excretion strategy for stem cell-generated embryonic kidneys. Proc. Natl. Acad. Sci. USA 112, 12980–12985 (2015).
Xinaris, C. et al. Functional human podocytes generated in organoids from amniotic fluid stem cells. J. Am. Soc. Nephrol. 27, 1400–1411 (2016).
Gardner, R. L. et al. Investigation of early mammalian development using interspecific chimaeras between rat and mouse. Nature 21, 86–89 (1973).
Wu, J. et al. Stem cells and interspecies chimaeras. Nature 540, 51–59 (2016).
Usui, J. et al. Generation of kidney from pluripotent stem cells via blastocyst complementation. Am. J. Pathol. 180, 2417–2426 (2012).
Kobayashi, T. et al. Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells. Cell 142, 787–799 (2010).
Kobayashi, T. et al. Targeted organ generation using Mixl1-inducible mouse pluripotent stem cells in blastocyst complementation. Stem Cells Dev. 15, 182–189 (2015).
Masaki, H. et al. Inhibition of apoptosis overcomes stage-related compatibility barriers to chimera formation in mouse embryos. Cell Stem Cell 19, 587–592 (2016).
Wu, J. et al. Dynamic pluripotent stem cell states and their applications. Cell Stem Cell 17, 509–525 (2015).
Taguchi, A. et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 14, 53–67 (2014).
Xia, Y. et al. Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells. Nat. Cell Biol. 15, 1507–1515 (2013).
Takasato, M. et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564–568 (2015).
Morizane, R. et al. Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells. Nat. Protoc. 12, 195–207 (2017).
Tanigawa, S. et al. Selective in vitro propagation of nephron progenitors derived from embryos and pluripotent stem cells. Cell Rep. S2211–1247, 30365 (2016).
Li, Z. 3D Culture supports long-term expansion of mouse and human nephrogenic progenitors. Cell Stem Cell 19, 516–529 (2016).
Kobayashi, A. et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 3, 169–181 (2008).
Short, K. M. et al. Global quantification of tissue dynamics in the developing mouse kidney. Dev. Cell 29, 188–202 (2014).
Little, M. H. et al. A high-resolution anatomical ontology of the developing murine genitourinary tract. Gene Expr. Patterns 7, 680–699 (2007).
Chen, S. et al. Intrinsic age-dependent changes and cell-cell contacts regulate nephron progenitor lifespan. Dev. Cell 35, 49–62 (2015).
Steenhard, B. M. et al. Integration of embryonic stem cells in metanephric kidney organ culture. J. Am. Soc. Nephrol. 16, 1623–1631 (2005).
Minuth, W. W. et al. Structural links between the renal stem/progenitor cell niche and the organ capsule. Histochem. Cell Biol. 141, 459–471 (2014).
Buch, T. et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2, 419–426 (2005).
Costantini, F. et al. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev. Cell 18, 698–712 (2010).
Georgas, K. et al. Analysis of early nephron patterning reveals a role for distal RV proliferation in fusion to the ureteric tip via a cap mesenchyme-derived connecting segment. Dev Biol. 15, 273–286 (2009).
Bohn, W. et al. Species-specific recognition patterns of monoclonal antibodies directed against vimentin. Exp Cell Res. 201, 1–7 (1992).
Grgic, I. et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int. 82, 172–183 (2012).
Saito, M. et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 19, 746–750 (2001).
Stanger, B. Z. et al. Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature 445, 886–891 (2007).
Ishii, T. et al. Transplantation of embryonic stem cell-derived endodermal cells into mice with induced lethal liver damage. Stem Cells 25, 3252–3260 (2007).
Sturzu, A. C. et al. Fetal mammalian heart generates a robust compensatory response to cell loss. Circulation 132, 109–121 (2015).
Self, M. et al. Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J. 25, 5214–5228 (2006).
Saxen, L. Organogenesis of the Kidney, Development and Cell Biology Series. (Cambridge University Press, Cambridge, UK, 1987).
Cebrian, C. et al. The number of foetal nephron progenitor cells limits ureteric branching and adult nephron endowment. Cell Rep. 7, 127–137 (2014).
Short, K. M. et al. The contribution of branching morphogenesis to kidney development and disease. Nat. Rev. Nephrol. 12, 754–767 (2016).
Little, M. H.et al Understanding kidney morphogenesis to guide renal tissue regeneration. Nat. Rev. Nephrol. 12, 624–635 2016).
Rashid, T. Revisiting the flight of Icarus: making human organs from PSCs with large animal chimeras. Cell Stem Cell 15, 406–409 (2014).
Wu, J. et al. Interspecies chimerism with mammalian pluripotent stem cells. Cell 168, 473–486 (2017).
Takasato, M. et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat. Cell Biol. 16, 118–126 (2014).
Sharmin, S. et al. Human induced pluripotent stem cell-derived podocytes mature into vascularized glomeruli upon experimental transplantation. J. Am. Soc. Nephrol. 27, 1778–1791 (2016).
Sasai, Y. Cytosystems dynamics in self-organization of tissue architecture. Nature 17, 318–326 (2013).
Yamaguchi, T. et al. Interspecies organogenesis generates autologous functional islets. Nature 9, 191–196 (2017).
Davies, J. A. The embryonic kidney: isolation, organ culture, immunostaining and RNA interference. Methods Mol. Biol. 633, 57–69 (2010).
Davies, J. A. et al. Dissociation of embryonic kidney followed by re-aggregation as a method for chimeric analysis. Methods Mol. Biol. 886, 135–146 (2012).
McMahon, A. P. et al. GUDMAP: the genitourinary developmental molecular anatomy project. J. Am. Soc. Nephrol. 19, 667–671 (2008).
We thank E. Kikuchi, H. Gotoh, and M. Ishida for experimental/technical assistance. Six2-Cre mice were gifted from Dr R. Nishinakamura (The Kumamoto University; Institute of Molecular Embryology and Genetics). This work was supported by grants from Japan Agency for Medical Research and Development (AMED) Grant Number 17ek0310006h0002 and Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 17K16102, 16H03175. This work also was supported technically by The Jikei University School of Medicine.
The authors declare no competing financial interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’sCreative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yamanaka, S., Tajiri, S., Fujimoto, T. et al. Generation of interspecies limited chimeric nephrons using a conditional nephron progenitor cell replacement system. Nat Commun 8, 1719 (2017). https://doi.org/10.1038/s41467-017-01922-5
This article is cited by
Advances in tissue engineering technology for kidney regeneration and construction
Journal of Artificial Organs (2022)
Generation of chimeric kidneys using progenitor cell replacement: Oshima Award Address 2021
Clinical and Experimental Nephrology (2022)
In vivo regeneration of interspecies chimeric kidneys using a nephron progenitor cell replacement system
Scientific Reports (2019)
Human kidney organoids: progress and remaining challenges
Nature Reviews Nephrology (2019)
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.